Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

3 clusters · 14 sources · 7 days · First seen 8 days ago · Last updated 1 day ago

Categories: HEALTH

Brazil expands Wolbachia mosquito releases

Entities: Institute of Molecular Biology of Paraná · Eduardo Pimentel · Wolbachia · World Mosquito Program · Aedes aegypti

Overview

Brazil’s health regulator Anvisa approved commercial production of Wolbachia‑modified male Aedes aegypti mosquitoes at a Flyttr factory in Campinas, enabling weekly output of millions of insects. The first field releases were launched in São José do Rio Preto, where Fiocruz and local health teams began weekly drops of Wolbachia‑infected males across ten priority neighborhoods in September‑October 2026, following a mapping of recent case concentrations. The 26‑week programme is coupled with community education to improve acceptance and complement existing vector‑control actions.

In July 2026 the municipality of Curitiba started its own 26‑week Wolbachia release campaign, deploying batches at Praça Professora Marli Queiroz de Azevedo in the Sítio Cercado district. The city reported a 94 % decline in dengue cases between January and July 2026, attributing the drop to a combination of clean‑up drives and the new Wolbachia programme. The initiative involves partnerships with Wolbito do Brasil, the Instituto de Biologia Molecular do Paraná and the World Mosquito Program, mirroring efforts in other Brazilian cities such as Niterói and Campo Grande. Both cities continue to monitor mosquito populations and disease incidence as the releases progress.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 3 SOURCES] Curitiba will begin releasing Wolbachia-infected Aedes aegypti mosquitoes on 29 July 2026 at 11:00 in Sítio Cercado. (Curitiba mosquitorelease initiative)
[● 3 SOURCES] The released mosquitoes are intended to reduce transmission of dengue, Zika and chikungunya. (Program description)
[● 3 SOURCES] Weekly releases will continue for approximately 26 weeks. (Program timeline)
[● 3 SOURCES] Between 1 January and 20 July 2026 Curitiba recorded a 94 % reduction in dengue cases compared with the same period in the previous year. (All three articles)
[● 3 SOURCES] Wolbachia bacteria does not genetically modify the mosquitoes and occurs naturally in many insect species. (Scientific explanation)
[● 3 SOURCES] Curitiba began releasing Wolbachia‑infected Aedes aegypti mosquitoes on July 29, 2026 in Sítio Cercado. (All three articles)
[● 3 SOURCES] The released mosquitoes carry Wolbachia, which reduces their ability to transmit dengue, Zika and chikungunya. (All three articles)
[● 3 SOURCES] The Wolbachia release program will run for approximately 26 weeks with weekly releases. (All three articles)
[● 3 SOURCES] The Wolbachia method uses a natural bacterium and does not involve genetic modification of the mosquitoes. (All three articles)
[● 3 SOURCES] The released mosquitoes are called “wolbitos”. (source)
[● 3 SOURCES] Wolbachia bacteria reduces the ability of Aedes aegypti to transmit dengue, Zika and chikungunya. (source)
[● 3 SOURCES] Curitiba mayor Eduardo Pimentel started releasing Wolbachia‑infected mosquitoes on July 29, 2026. (All articles)

Timeline

1 day ago

[HEALTH] 6 sources
Curitiba launches Wolbachia mosquito release to curb dengue
Curitiba began weekly releases of Wolbachia‑infected mosquitoes on July 29 2026 to cut dengue transmission after a 94% case drop; the 26‑week program is deemed safe and partners with Wolbito do Brasil and the W
4 days ago

[HEALTH] 6 sources
São José do Rio Preto releases Wolbachia‑infected mosquitoes to fight dengue
São José do Rio Preto will release Wolbachia‑infected mosquitoes in ten neighborhoods from September 2026 to curb dengue, Zika and chikungunya, following a partnership with Fiocruz and past successes in Brazil.
8 days ago

[HEALTH] 2 sources
Anvisa approves production of Wolbachia-modified mosquitoes in Brazil
Anvisa has approved commercial production of Wolbachia‑modified male mosquitoes in Campinas, aiming to curb dengue, Zika and chikungunya in Brazil.

Sources

actu.capital.fr · ama-al.com.br · esmaelmorais.com.br · fooba.com.br · jblog.com.br · jornale.com.br · nx1.com.br · omatogrosso.com · portaln10.com.br · portalwcbnews.com.br · regiaonoroeste.com · reportermt.com · rpnews.com.br · tribunapr.com.br

This summary has been updated 3 times: see revision history